Phase I/II Study of Lenalidomide Plus Pembrolizumab in Patients With Solid Tumors With Expansion in Non-small Cell Lung Cancer

Stopped Study terminated prematurely due to funding/support being withdrawn by grantor

Conditions

• Relapsed or Refractory Solid Tumors
• Nonsmall Cell Lung Cancer

Interventions

• DRUG: Lenalidomide
• DRUG: Pembrolizumab

Sponsor

Fox Chase Cancer Center

Collaborators

• [object Object]
• [object Object]